Genetic Technologies Limited Asset Turnover Ratio (GENE), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Genetic Technologies Limited  (GENE)
 

Genetic Technologies Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Genetic Technologies Limited asset turnover ratio, the ability of Genetic Technologies Limited's assets to generate revenue in the fourth quarter 2024, increased sequentially to 1.32 in the fourth quarter (Jun 30 2024), GENE's balance sheet remain strong.

Within sector 70 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2024 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GENE Asset Turnover Ratio (Jun 30 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2019)
IV. Quarter
Y / Y Asset Change -63.14 % 134.95 % 42.74 % 135.46 % 414.09 %
Y / Y Revenue Change 30024.13 % - - - -86.56 %
Asset Turnover Ratio (TTM) 1.32 - - - 0
GENE's Total Ranking # # # # #
Seq. Asset Change 0 % 32.75 % -24.67 % -63.14 % 537.47 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 71
Healthcare Sector # 642
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0.03 0.02 0.01
(Jun 30 2018)   (Jun 30 2019)




GENE Company Profile • Back to GENE Efficiency Comparisons • Compare GENE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Assets at quarter ending Jun 30 2024
Longduoduo Co Ltd  3.29 $ 7.390  Millions$ 2.247  Millions
Lifemd Inc   3.15 $ 176.873  Millions$ 56.112  Millions
Lifevantage Corp  3.14 $ 199.724  Millions$ 63.583  Millions
Interpace Biosciences Inc   3.12 $ 40.852  Millions$ 13.096  Millions
Bespoke Extracts Inc  2.86 $ 1.047  Millions$ 0.366  Millions
Jrsis Health Care Corp  2.61 $ 4.516  Millions$ 1.733  Millions
Escalon Medical Corp   2.52 $ 11.982  Millions$ 4.748  Millions
Agilon Health Inc   2.41 $ 5,118.276  Millions$ 2,124.680  Millions
Hims and Hers Health Inc   2.39 $ 1,067.729  Millions$ 445.914  Millions
Dih Holding Us Inc   2.36 $ 112.297  Millions$ 47.621  Millions
Patterson Companies Inc   2.25 $ 6,533.796  Millions$ 2,900.282  Millions
Healthcare Services Group Inc   2.14 $ 1,684.949  Millions$ 786.238  Millions
Zeo Scientifix Inc   2.05 $ 4.798  Millions$ 2.342  Millions
Biotricity Inc   2.04 $ 12.270  Millions$ 6.005  Millions
Greenbrook Tms Inc   2.02 $ 116.485  Millions$ 57.677  Millions
Biofrontera Inc   1.96 $ 52.984  Millions$ 27.046  Millions
Integrated Biopharma Inc  1.89 $ 49.884  Millions$ 26.378  Millions
Avenir Wellness Solutions Inc   1.88 $ 3.890  Millions$ 2.068  Millions
Champions Oncology Inc   1.82 $ 51.655  Millions$ 28.418  Millions
Nature s Sunshine Products inc   1.82 $ 441.734  Millions$ 243.196  Millions
Molecular Templates Inc   1.81 $ 60.307  Millions$ 33.315  Millions
Medinotec Inc   1.80 $ 6.931  Millions$ 3.845  Millions
Rockwell Medical inc   1.78 $ 92.909  Millions$ 52.133  Millions
The Oncology Institute Inc   1.78 $ 361.067  Millions$ 202.932  Millions
Evofem Biosciences Inc   1.74 $ 17.714  Millions$ 10.161  Millions
Rosecliff Acquisition Corp I  1.72 $ 22.531  Millions$ 13.101  Millions
Neuraxis Inc   1.70 $ 2.267  Millions$ 1.331  Millions
Psychemedics Corporation  1.69 $ 20.169  Millions$ 11.924  Millions
Sunlink Health Systems Inc   1.68 $ 32.442  Millions$ 19.316  Millions
Privia Health Group Inc   1.65 $ 1,695.679  Millions$ 1,025.359  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.